Yves Cornellier
Gründer bei Alethia Biotherapeutics, Inc.
Profil
Yves Cornellier founded Alethia Biotherapeutics, Inc. in 2002, where he is working as President, Chief Executive Officer & Director from 2002.
Mr. Cornellier also founded Seyvika Pharmaceuticals.
Mr. Cornellier also formerly worked at 9342-8530 Québec, Inc., as Director, LAB International, Inc., as Senior Vice President-Business Development, Theratechnologies, Inc., as VP-Business Development & Commercialization, Miles Laboratories, Inc., as Principal, Abbott Laboratories Ltd., as Senior Marketing Manager, and Glaxo Canada, Inc., as Principal.
Aktive Positionen von Yves Cornellier
| Unternehmen | Position | Beginn |
|---|---|---|
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Gründer | 01.01.2002 |
Ehemalige bekannte Positionen von Yves Cornellier
| Unternehmen | Position | Ende |
|---|---|---|
Miles Laboratories, Inc.
 Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Corporate Officer/Principal | - |
| Glaxo Canada, Inc. | Corporate Officer/Principal | - |
Abbott Laboratories Ltd.
 Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Vertrieb & Marketing | - |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| 9342-8530 QUÉBEC INC. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
Seyvika Pharmaceuticals
 Seyvika Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Seyvika Pharmaceuticals researches and develops drugs for the treatment of asthma. The company is based in Montréal, Canada. The Canadian company was founded by Yves Cornellier. Seyvika Pharmaceuticals was acquired by LAB International, Inc. on October 02, 2003 for $2.23 million. | Commercial Services |
Miles Laboratories, Inc.
Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Miles Laboratories, Inc. manufactures pharmaceutical products. The company is based in Rexdale, Canada. | Health Technology |
Abbott Laboratories Ltd.
Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Health Technology |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
| Glaxo Canada, Inc. |
